ClinicalTrials.gov
public full text
Public Domain
Haploidentical Lymphocytes With Nivolumab/Ara-C as Consolidation in Elderly AML Patients
A phase II trial to compare the efficacy and safety of nivolumab and intermediate dose cytarabine with or without haploidentical lymphocyte infusion. To identify the role of haploidentical lymphocytes in the treatment of acute myeloid leukemia in older adults. The patients will be stratified based on the remission number (first or second)
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL#904486
- Non-Hodgkin Lymphoma in Elderly Patients Above the Age of 80 in the Rituximab Era#980185
- Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early Relapse#1058913
- Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation#892536
- Treatment of Elderly Chinese Acute Myeloid Leukemia Patients Aged 65 to 75 Years Old#1140007
Record · ID 1046078
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive